What Is Ketamine Therapy? A Beginner’s Guide

Ketamine therapy is an emerging treatment option for certain mental health conditions — most commonly treatment‑resistant depression — and, in some settings, severe suicidal ideation. Originally developed as an anesthetic in the 1960s, ketamine is now being used at much lower, sub‑anesthetic doses to target mood symptoms.

If you’re hearing about ketamine for the first time, here’s what you need to know.

1. What Is Ketamine?

Ketamine is a medication that works differently from traditional antidepressants.

Most standard antidepressants affect serotonin, norepinephrine, or dopamine and can take 4–8 weeks to show benefit. Ketamine acts primarily on the NMDA (N‑methyl‑D‑aspartate) receptor, part of the brain’s glutamate system, which is involved in mood regulation and neuroplasticity.

Because of this different mechanism, ketamine can sometimes produce improvement within hours to days, rather than weeks.

2. What Conditions Is Ketamine Used For?

Ketamine therapy is most commonly used for:

• Treatment‑resistant depression (depression that has not improved after multiple medication trials)

• Major depression with suicidal thoughts (short‑term symptom reduction)

• Some anxiety and trauma‑related conditions (in select cases)

  
  

In the United States, intranasal esketamine (Spravato) is FDA‑approved for treatment‑resistant depression and for depression with acute suicidal ideation. Intravenous ketamine is often used off‑label in psychiatric settings.

Ketamine is generally considered after standard treatments have not worked, not as a first‑line therapy.

3. How Does Ketamine Therapy Work?

Researchers believe ketamine:

• Enhances glutamate signaling

• Promotes synaptic growth and neuroplasticity

• Rapidly interrupts depressive circuitry

  
  

In clinical studies, many patients experience:

• Reduced depressive symptoms within 24 hours

• Improvement in suicidal thoughts within hours

• Benefit lasting 1–2 weeks after a single dose

  
  

Because effects can fade, treatment is often delivered in a series (commonly 6–8 sessions over several weeks), followed by individualized maintenance.

4. What Is a Typical Treatment Like?

While protocols vary, a common intravenous ketamine approach includes:

• Dose: 0.5 mg/kg

• Infused over 40-60 minutes

• Monitoring of blood pressure, pulse, and oxygen levels

• Observation for approximately 1–2 hours total

  
  

Esketamine (intranasal) is self‑administered in clinic under supervision and requires monitoring for at least 2 hours due to FDA safety requirements.

Patients typically:

• Remain awake

• May experience dissociation (a dream‑like or floating sensation)

• Cannot drive the same day

• Need a ride home

5. Is Ketamine Safe?

At sub‑anesthetic psychiatric doses and in medically screened patients, ketamine is generally well tolerated.

Common short‑term side effects include:

• Temporary increase in blood pressure

• Nausea

• Dizziness

• Dissociation or perceptual changes

• Fatigue afterward

  
  

Serious medical adverse events are rare in screened populations. Most psychiatric protocols exclude patients with:

• Uncontrolled cardiovascular disease

• Active psychosis

• Pregnancy

• Severe liver disease

  
  

Because ketamine has abuse potential at high or repeated recreational doses, treatment should occur in a structured medical setting with monitoring.

6. How Effective Is It?

Response rates vary, but in large pooled analyses:

• Up to 79% of patients respond to IV ketamine

• Degrees of improvement can vary widely among patients

• Some individuals respond rapidly; others do not

  
  

Currently, there are no reliable predictors of who will respond. Many clinicians use a brief trial (1–3 infusions) to assess early benefit.

Ketamine is not a cure. It is best viewed as a tool within a broader treatment plan, often combined with ongoing medication management and psychotherapy.

7. Is Ketamine the Same as “Ketamine-Assisted Psychotherapy”?

Not necessarily.

Ketamine can be administered:

• As a medical infusion alone

• Alongside structured psychotherapy before, during, or after sessions

  
  

Research into ketamine‑assisted psychotherapy is ongoing. While early findings are promising, there is no single standardized protocol yet.

8. Who Might Consider Ketamine Therapy?

You may consider discussing ketamine therapy if you:

• Have major depression that has not improved with at least two medications

• Cannot tolerate traditional antidepressants

• Have persistent suicidal thoughts requiring rapid intervention

• Have exhausted other evidence‑based options

  
  

Ketamine is generally not recommended as a first treatment for newly diagnosed depression.

9. What Are the Limitations?

Important considerations include:

• Effects may be temporary

• Maintenance treatments may be required

• Insurance rarely covers treatments

• Long‑term safety data are still evolving

• Not all patients respond

  
  

Ketamine should be delivered in a clinic with:

• Psychiatric oversight

• Medical monitoring

• Clear screening protocols

• A structured follow‑up plan

Final Thoughts

Ketamine therapy represents one of the most significant advances in depression treatment in decades because of its rapid onset of action. For patients who have struggled for years without relief, it can offer meaningful improvement — sometimes quickly.

However, it is not a miracle cure and works best when integrated into comprehensive psychiatric care.

If you’re exploring treatment options for difficult‑to‑treat depression, ketamine may be worth learning more about — especially if traditional approaches have not provided adequate relief.